1. Home
  2. PCLA vs PPCB Comparison

PCLA vs PPCB Comparison

Compare PCLA & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$2.25

Market Cap

9.6M

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.13

Market Cap

3.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PCLA
PPCB
Founded
2008
2007
Country
Japan
Australia
Employees
55
N/A
Industry
Building Products
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6M
3.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCLA
PPCB
Price
$2.25
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.8K
984.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.12
52 Week High
$8.00
$10.69

Technical Indicators

Market Signals
Indicator
PCLA
PPCB
Relative Strength Index (RSI) 29.52 26.20
Support Level $0.35 N/A
Resistance Level $3.74 $0.40
Average True Range (ATR) 0.44 0.02
MACD -0.29 0.00
Stochastic Oscillator 0.00 8.62

Price Performance

Historical Comparison
PCLA
PPCB

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: